Stay updated on Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The latest record now shows Revision: v3.3.2 in the history, with v3.3.1 removed from the list. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T15:39:02.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.3.1 replaces v3.2.0; no substantive changes to the study record content or data are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:43:52.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the notice about government funding delays and potential information currency from the page header. The page now presents the standard study details without that disclaimer.
    Difference
    0.5%
    Check dated 2025-11-17T06:20:46.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    No significant content changes detected between the old and new versions; the updates appear to be minor UI/layout adjustments to the page header and navigation while study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:58:24.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    - Added a government funding notice about potential delays and current operating status, plus a link to cc.nih.gov and opm.gov for updates. - Bumped version from v3.1.0 to v3.2.0.
    Difference
    11%
    Check dated 2025-10-05T10:04:41.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a v3.1.0 release has superseded v3.0.2.
    Difference
    0.3%
    Check dated 2025-09-28T03:12:44.000Z thumbnail image

Stay in the know with updates to Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.